RECENT NEWS Todo(s)Alzheimer'sBipolarDepressionMigraineParkinson'sSchizophrenia Migraine 23 Feb, 2024 Read Time: 4 mins Satellite symposium Unveiling the Migraine Mystery: Exposing the Depths of Migraine Suffering Burden of Migraine: Identifying Unmet Needs At the recent 4th Dubai Neurology Congress, UAE (23... Schizophrenia 15 Oct, 2023 Read Time: 4 mins Satellite symposium Tracing the Arc of Progress: A Historical Exploration of Evolving Schizophrenia Treatments and Treatment Goals What series of small steps can promote and maintain functional recovery in patients with... Depression 15 Oct, 2023 Read Time: 4 mins Satellite symposium Navigating the Emotional Labyrinth in MDD Initiating and optimizing treatment for patients with Major Depressive Disorder During The 27th... Depression 15 Oct, 2023 Read Time: 4 mins Satellite symposium The Complex Intertwine of MDD and GAD Initiating and optimizing treatment for patients with Major Depressive Disorder During the 27th... Migraine 15 Oct, 2023 Read Time: 3 mins Satellite symposium Congress highlights A New Era in Migraine Therapy: Unpacking the Potentials of IV anti-CGRP monoclonal antibodies Exploring the Key Considerations for Prescribing Anti-CGRPs – Advantages of Eptinezumbab During The... Migraine 15 Oct, 2023 Read Time: 3 mins Satellite symposium Congress highlights Guarding Against the Grind: Migraine Prevention Essentials Understanding the Patient’s Needs in Migraine Management: The Right Plan for the Right... Migraine 15 Oct, 2023 Read Time: 3 mins Satellite symposium Congress highlights Navigating Migraine Mazes: A Compass to Individualized Care Understanding the Patient’s Needs in Migraine Management: The Right Plan for the Right... Depression 15 Jun, 2023 Read Time: 2 mins Congress highlights Unlocking the Emotional Maze: Exploring Emotional Blunting and Anhedonia During the 18th International Congress on Psychiatry and the 6th International Congress on Child... Depression 15 Jun, 2023 Read Time: 4 mins Congress highlights Untangling the Threads: Delving into the Complexities and the Management of Depression During the 18th International Congress on Psychiatry and the 6th International Congress on Child... 08 May, 2023 Read Time: 2 mins Congress highlights Female inmates with a lifetime history of trauma and mental illness. Focus on trauma and the interaction with forensic psychiatry At the recent South African Biological Psychiatry Congress, held in September 2022, Dr Samantha... 08 May, 2023 Read Time: 2 mins Congress highlights The Covid-19 pandemic and OCD: A devastating duo? OCD and disorders on the spectrum: Different sides of the same coin During the recent South African Biological Psychiatry Congress held in Cape Town in 2022, Obsessive... 08 May, 2023 Read Time: 2 mins Congress highlights Exploring trauma histories among forensic state patients charged with murder At the recent South African Biological Psychiatry Congress, which took place in September 2022, Prof... Mental-Health 30 Oct, 2022 Read Time: 3 mins Congress highlights Article A child psychiatrist’s perspective on current treatment options During the third multidisciplinary South African congress for ADHD, Dr Brendan Belsham, a child and... Mental-Health 30 Oct, 2022 Read Time: 3 mins Congress highlights Article New Perspectives on Research and Clinical Care for ADHD During the 3rd South Africa Multidisciplinary Congress for ADHD, Prof Stephen Faraone presented... Depression 28 Oct, 2022 Read Time: 3 mins Article Treatment Resistant Depression: Causes, Consequences and Cures’ During the Biological Psychiatry Congress held in Cape Town, South Africa in September 2022, Dr Allan... Depression 28 Oct, 2022 Read Time: 3 mins Congress highlights Redefining Treatment Expectations in Major Depressive Disorder (MDD) Depression still leads the way in terms of the global burden of disease. In a seminar, sponsored by... Depression 20 Oct, 2022 Read Time: 7 mins Satellite symposium Article Optimising outcomes in major depressive disorder At the 35th ECNP Congress in Vienna, Austria (15−18th Oct), in a symposium titled ‘Optimising... Bipolar, Schizophrenia 20 Oct, 2022 Read Time: 3 mins Article Highlights from ECNP 2022 – Day 4 – October 18th Welcome to Progress in Mind’s live coverage of ECNP 2022. The 35th Congress of the European College... Depression, Schizophrenia 19 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights from ECNP 2022 – Day 3 – October 17th Welcome to Progress in Mind’s live coverage of ECNP 2022. The 35th Congress of the European College... Depression, Anxiety 18 Oct, 2022 Read Time: 5 mins Satellite symposium Article Improving functioning as a treatment goal in comorbid major depressive disorder and generalized anxiety disorder At the 35th ECNP Congress in Vienna, Austria (15−18th October), in a symposium entitled ‘Functioning... Mental Health 18 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights from ECNP 2022 – Day 2 – October 16th Welcome to Progress in Mind’s live coverage of ECNP 2022. The 35th Congress of the European College... Mental Health 17 Oct, 2022 Read Time: 4 mins Congress highlights Article Highlights from ECNP 2022 – Day 1 – October 15th Welcome to Progress in Mind’s live coverage of ECNP 2022. The 35th Congress of the European College... Schizophrenia 11 Oct, 2022 Read Time: 0 min Infographic Global burden of schizophrenia today Depression 11 Oct, 2022 Read Time: 0 min Infographic Depression - a growing health concern Mental Health 10 Oct, 2022 Read Time: 4 mins Article Meeting migraine’s mental health challenge Mental health comorbidities are common in chronic migraine, with anxiety and depression reported by a... 10 Oct, 2022 World Mental Health Day 2023 10 October is World Mental Health Day, which aims to raise awareness of mental health worldwide and... Mental Health 05 Oct, 2022 Read Time: 4 mins Congress highlights Article Is the DSM still relevant to psychiatry? This APA Online 2022 session focused on the future of the DSM, and how it can remain relevant to the... Schizophrenia 05 Oct, 2022 Read Time: 3 mins Congress highlights Article What should psychiatrists do to improve the physical health of patients with schizophrenia? The life expectancy of people with schizophrenia is 14.5 years less than that of the general... PTSD 03 Oct, 2022 Read Time: 3 mins Satellite symposium Congress highlights Integrated National Strategy to Curb Violence Against Women Violence Against Women (VAW) is a global public health concern. The WHO estimates that about 1 in 3... Depression, PTSD 03 Oct, 2022 Read Time: 3 mins Satellite symposium Congress highlights Digital Psychiatry: The Pros and Cons of Digital Mental Health Care in Children & Adolescents In the post-COVID-19 era, the increased utilization of Telemedicine comes as no surprise;... Schizophrenia 03 Oct, 2022 Read Time: 3 mins Satellite symposium Congress highlights Culture and Psychiatry: Challenges and opportunities Culture is a set of behavioral norms and ideas adopted by a particular society, through which they... Depression, PTSD 21 Sep, 2022 Read Time: 3 mins Satellite symposium Broken Families: Challenging & Opportunities Divorce rate in Egypt has seen a profound increase of 83% between 1996 and 2017. From a rate of 1.2... Depression 15 Sep, 2022 Read Time: 3 mins Satellite symposium Congress highlights Exploring dose–response relationships of antidepressant treatments: Efficacy and tolerability considerations Nausea, constipation, diarrhea, dry mouth, headache, dizziness, nervousness, agitation, insomnia,... Depression 15 Sep, 2022 Read Time: 4 mins Satellite symposium Congress highlights Identifying and achieving treatment goals in MDD: What matters most to patients? A large proportion of patients with MDD fail to show adequate response to first-line antidepressants.... Depression 15 Sep, 2022 Read Time: 5 mins Satellite symposium Congress highlights Anhedonia, emotional blunting and low motivation in MDD: What are the implications for functional recovery? Besides sadness and anxiety, the emotional symptoms of depression also include the devastating... Depression 25 Aug, 2022 Read Time: 3 mins Article Mental Agility and the Three Musketeers: Cognition, Emotion and Motivation A current investigation into behavioural health literature shows an emphasis on the hot topic of... Load More Alzheimer's Disease 13 May, 2020 Read Time: 2 mins Congress highlights Further evidence of cognitive and health benefits extends lifestyle intervention The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)... Alzheimer's Disease, Parkinson's Disease 16 Apr, 2020 Read Time: 2 mins Article COVID-19 and Dementia: a conjunction of pandemics The complexities of preventing and managing infection are multiplied in people living with dementia.... Alzheimer's Disease 03 Apr, 2020 Read Time: 2 mins Congress highlights Plenty of key targets in the dynamic Alzheimer’s pipeline Far from running dry, the pipeline is well provided with agents in development for Alzheimer’s... Mental Health 22 Mar, 2020 What role should patients play in treatment decision making? Mental Health 14 Feb, 2020 Read Time: 3 mins Article Real-world evidence — raising organizational fluency through interactive learning techniques Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and... Alzheimer's Disease 23 Jan, 2020 Read Time: 3 mins Congress highlights Assessing and managing agitation associated with Alzheimer’s dementia Agitation is common among patients with Alzheimer’s disease (AD) and results in a range of behavioral... Mental Health 14 Nov, 2019 Read Time: 3 mins Congress highlights Can blue-depleted light decrease duration of psychiatric hospitalization? Novel light and sensor technologies have been installed in a new acute psychiatric unit in Norway to... Alzheimer's Disease 06 Sep, 2019 Read Time: 3 mins Congress highlights Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease? The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of... Alzheimer's Disease 06 Sep, 2019 Read Time: 3 mins Congress highlights The emerging relationship between plasma and brain amyloid-β — does it play a role in the pathogenesis in Alzheimer’s disease? Reliable plasma amyloid-β (Aβ) measurement is now possible using new highly sensitive techniques, and... Alzheimer's Disease 22 Jul, 2019 Read Time: 3 mins Congress highlights Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease? The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of... Alzheimer's Disease 10 Apr, 2019 Read Time: 4 mins Congress highlights Making ready for early AD diagnosis When disease-modifying therapy becomes available, screening for Alzheimer’s and its subsequent... Alzheimer's Disease 05 Apr, 2019 Read Time: 3 mins Congress highlights Encouraging immune response to AD: adjuvants, modifying the microbiome, and microglial rejuvenation Modulating central and peripheral innate immunity has potential in Alzheimer’s Disease. Following... Load More Mental Health 14 Nov, 2019 Read Time: 3 mins Congress highlights Can blue-depleted light decrease duration of psychiatric hospitalization? Novel light and sensor technologies have been installed in a new acute psychiatric unit in Norway to... Mental Health 30 Oct, 2019 Read Time: 3 mins Congress highlights The new technologies transforming psychiatric practice and patient outcomes Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information... Mental Health 20 Aug, 2019 Read Time: 3 mins Congress highlights Beyond the guidelines: Precision Medicine Despite the attractiveness of precision medicine (PM) for providing personalized patient management,... Mental Health 04 Jun, 2019 Read Time: 3 mins Congress highlights A public invitation to view and comment on pre-final APA schizophrenia guideline statements Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two... Mental Health 04 Jun, 2019 Read Time: 3 mins Congress highlights What is the role of inflammation in the pathophysiology of mood disorders? Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology and... Mental Health 10 Apr, 2019 Read Time: 4 mins Congress highlights Psychiatrist and patient partnership encourages trust and effective care We have so many shared objectives – notably ensuring adequate resources are given to mental health –... Mental Health 10 Apr, 2019 Read Time: 4 mins Congress highlights Potential new targets in depression and schizophrenia – learnings from obesity and exercise Weight loss and exercise increase benefit for mental health, but are difficult to achieve. The... Mental Health 22 Feb, 2019 Read Time: 3 mins Congress highlights Developments in disease understanding aid treatment innovation Instead of assigning patients with psychosis to diagnostic categories, we might concentrate on the... Depression, Bipolar 20 Feb, 2019 Read Time: 3 mins Article Predicting vulnerability to mood disorders and treatment response Major depressive disorder (MDD) is ultimately about how the brain responds to the environment, but... Bipolar, Schizophrenia 11 Feb, 2019 Read Time: 3 mins Congress highlights Reconceptualizing psychosis based on biomarker analysis – personalized therapy to prevent disease progression When an extensive biomarker study characterizing diverse aspects of brain function unexpectedly... Mental Health 04 Feb, 2019 Read Time: 3 mins Article Train, test, predict: Using big data and machine learning in psychiatry Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine clinical... Depression, Bipolar 31 Jan, 2019 Read Time: 2 mins Article Inform, track and treat: New tools to identify and address cognitive symptoms in mood disorders Brain health is important to us all, and cognitive impairment causes significant morbidity. Cognition... Load More Mental Health 06 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Mental Health 05 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 3 — October 4th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Mental Health 04 Oct, 2021 Read Time: 4 mins Congress highlights Highlights from ECNP 2021 — Day 2 — October 3rd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Depression 03 Oct, 2021 Read Time: 4 mins Satellite symposium Potential treatment options for trauma-associated depression and emotional blunting Mass traumatic events, such as the global COVID-19 pandemic, significantly impact on mental health,... Mental Health 03 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 1 — October 2nd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Depression 20 Sep, 2021 Read Time: 2 mins Congress highlights What happens in the brain during a major depressive episode? At any one time, 4% of the population is experiencing a major depressive episode,1 said Professor... Depression, Schizophrenia 06 Sep, 2021 Read Time: 2 mins Congress highlights Quarantines, lockdowns, and social isolation: What are we brewing? The COVID-19 pandemic continues to impact well-being across the globe. Lockdowns, quarantine, and... Depression 20 Jul, 2021 Read Time: 3 mins Satellite symposium Promising data in depression associated with emotional blunting or trauma Treatment for depression should be tailored to individuals’ history and presentation. Patients with... Depression, Schizophrenia 17 Mar, 2021 Read Time: 3 mins Satellite symposium Patient engagement: A new concept in patient-centric functional recovery Patient engagement – a concept that includes life fulfillment, well-being and participation in daily... Depression, Schizophrenia 19 Feb, 2021 Read Time: 4 mins Congress highlights Why do we need new treatments for major depressive disorder and schizophrenia? Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as... Mental Health 08 Jan, 2021 Podcast Digital technologies - an opportunity to achieve Mental Health for All Digital technologies have the potential to transform the theme for World Mental Health Day 2020 —... Depression 02 Jan, 2021 Read Time: 3 mins Article Why do antidepressants cause emotional blunting and what can be done to resolve it in clinical practice? Emotional blunting describes an indifferent, unresponsive affect and inability to feel emotions... Load More Migraine 20 Jun, 2021 Read Time: 4 mins Congress highlights Real world evidence for CGRP antibodies in migraine prevention In a topical symposium at #EAN2021, three speakers discussed what is new on targeting CGRP for... Migraine, Alzheimer's Disease 20 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 2 The exciting live and connected virtual experience for presenters and attendees of the 7th Congress... Migraine 20 Jun, 2021 Read Time: 3 mins Congress highlights Do preventive anti CGRP treatments have a role in the acute migraine attack? Antibodies against the sensory neuropeptide calcitonin gene‑related peptide (CGRP) are showing... Migraine, Alzheimer's Disease 19 Jun, 2021 Read Time: 3 mins Congress highlights Highlights from EAN 2021 — Day 1 Welcome to Progress in Mind’s live coverage of EAN 2021. This 7th Congress of the European Academy of... Migraine 15 Jun, 2021 Read Time: 3 mins Congress highlights Can chronic migraine be prevented by targeting risk factors? Many risk factors have been identified for predicting the transition from episodic to chronic... Migraine 15 Jun, 2021 Read Time: 2 mins Congress highlights Preventive therapy reduces interictal burden of migraine The impact of migraine on a person’s life is multi-faceted; not only is there substantial functional... Migraine 15 Jun, 2021 Read Time: 2 mins Congress highlights Steps towards improving quality of life for patients with migraine Is it necessary to consider both patients and treating physicians’ views when investigating therapy... Migraine 15 Jun, 2021 Read Time: 2 mins Congress highlights Who should have migraine preventive treatment and how effective are these therapies? Migraine preventive therapy is used to reduce frequency, duration, or severity of attacks of episodic... Migraine 15 Jun, 2021 Read Time: 3 mins Congress highlights Preclinical pearls offer insights into migraine sex differences and sensory thresholds Speaking at #MTIS2020, Professor Frank Porreca, University of Arizona, USA, identified recent pearls... Migraine 15 Jun, 2021 Read Time: 2 mins Congress highlights Why is migraine more common in women? Migraine is twice as prevalent in women than in men.1 Estrogen is a predisposing factor with... Migraine 20 Apr, 2021 Read Time: 2 mins Satellite symposium How does chronic migraine affect everyday life? The disabling headaches and symptoms of chronic migraine can impact almost every aspect of life. What... Mental Health 03 Oct, 2020 Read Time: 2 mins Congress highlights Brain health becomes a global priority For years, the massive burden of mortality and morbidity caused by neurological diseases was not... Load More Parkinson's Disease 12 Apr, 2017 Read Time: 4 mins Congress highlights Pathways to cell death Both mitochondrial and lysosomal function decrease with age, which is the major risk factor for PD,... Parkinson's Disease 12 Apr, 2017 Read Time: 4 mins Congress highlights Plea for personalised medicine in PD Well-established therapies for Parkinson’s Disease focus on motor symptoms. In comparison, the... Parkinson's Disease 11 Apr, 2017 Read Time: 1 min Interview Looking forward and back: two hundred years of the “Shaking Palsy” Parkinson’s Disease now seems more complicated, and to have a longer prodrome than once thought. The... Mental Health 01 Apr, 2017 Read Time: 6 mins Current review Picking threads from the rich tapestry of 2016 A round-up from refugee mental health to cognitive training and the effects of a light-box on... Alzheimer's Disease, Parkinson's Disease 30 Mar, 2017 Read Time: 5 mins Article Big Data - Big Opportunities Scientists are working to harness the power of “big data” compiled from internet-connected devices.... Alzheimer's Disease, Parkinson's Disease 17 Feb, 2017 Read Time: 5 mins Current review To sleep or not to sleep: links with neurodegenerative disease Disrupted sleep is a major consequence of Alzheimer’s Disease, but could it also help cause the... Alzheimer's Disease, Parkinson's Disease 22 Jun, 2016 Read Time: 3 mins Congress highlights Highlights from the neurodegenerative disease sessions Primary progressive aphasia, amyloid PET in Alzheimer’s diagnosis, treating Parkinson’s tremor, and... Parkinson's Disease 15 Jun, 2016 Read Time: 2 mins Congress highlights Neglected problems of speech and swallowing respond to integrated management Speech problems can appear before classical Parkinsonian symptoms and are a sensitive marker of... Parkinson's Disease 15 Jun, 2016 Read Time: 3 mins Congress highlights Biomarkers chart path from prodrome to Parkinson’s Disease Reliable biomarkers of high risk would open up the prospect of preventing Parkinson’s Disease during... Parkinson's Disease 09 Jun, 2016 Read Time: 4 mins Congress highlights Quality of life, quality of care: shared perspectives in Parkinson’s Disease For both practical and ethical reasons, managing chronic conditions such as Parkinson’s Disease... Parkinson's Disease 09 Jun, 2016 Read Time: 4 mins Congress highlights Non-motor symptoms in Parkinson’s Disease: burden and role in possible prodrome Parkinson’s Disease is not just a disease of the brain, it is not just a disease of dopamine, and –... Schizophrenia 20 Jul, 2021 Read Time: 2 mins Article ‘A Stitch in Time – Managing Schizophrenia Effectively Long Term’ The treatment of chronic illnesses commonly includes the long-term use of pharmacotherapy. However,... Schizophrenia 12 Apr, 2021 Read Time: 3 mins Satellite symposium Long-acting injectables together with medical team training may facilitate functional recovery Early use of long-acting injectables together with targeted staff training may facilitate short- and... Depression, Schizophrenia 17 Mar, 2021 Read Time: 3 mins Satellite symposium Patient engagement: A new concept in patient-centric functional recovery Patient engagement – a concept that includes life fulfillment, well-being and participation in daily... Schizophrenia 17 Mar, 2021 Read Time: 3 mins Satellite symposium Life engagement is focus of patient-centered functional recovery Enhancing engagement with life is a key target of treatment in schizophrenia and extends beyond... Schizophrenia 08 Mar, 2021 Read Time: 2 mins Satellite symposium Early onset schizophrenia needs patient-specific management Early diagnosis and effective, well-tolerated treatment of early-onset schizophrenia are crucial to... Depression, Schizophrenia 19 Feb, 2021 Read Time: 4 mins Congress highlights Why do we need new treatments for major depressive disorder and schizophrenia? Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as... Schizophrenia 15 Feb, 2021 Read Time: 3 mins Interview Treatment goals in schizophrenia Dr Miquel Bioque, Hospital Clinic, Barcelona, talks to our correspondent about the need to change... Schizophrenia 14 Feb, 2021 Read Time: 6 mins Congress highlights Finding the sweet spot for pharmacotherapy in schizophrenia Over recent years, the goals in the management of patients with schizophrenia have evolved from... Schizophrenia 11 Feb, 2021 Read Time: 1 min Congress highlights Long-acting injectables – functioning and compliance studies Two posters presented during SIRS 2019 suggest that use of long-acting injectable (LAI) antipsychotic... Schizophrenia 03 Feb, 2021 Read Time: 3 mins Satellite symposium Balancing efficacy and tolerability to personalize treatment choices in schizophrenia The Precision Medicine Initiative was launched in 2015 in the United States. This approach to disease... Schizophrenia 02 Feb, 2021 Read Time: 3 mins Satellite symposium Why use of long acting injectables is an urgent issue Long acting injectable antipsychotics are often withheld until later stages of schizophrenia, but... Schizophrenia 02 Feb, 2021 Read Time: 2 mins Satellite symposium The importance of patient functioning in schizophrenia Speakers at this satellite symposium discussed the importance of addressing not just the symptoms of... Load More Most Popular Pagination Previous page ‹‹ Page 2
